UM  > Faculty of Health Sciences  > DEPARTMENT OF PHARMACEUTICAL SCIENCES
Residential Collegefalse
Status已發表Published
Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo
YANG Bin-rui1; HONG Si-jia1,2; Simon Ming-Yuen Lee1; CONG Wei-hong3; WAN Jian-bo1; ZHANG Zhe-rui1; ZHANG Qing-wen1; ZHANG Yi1; WANG Yi-tao1; LIN Zhi-xiu2
2014-12-22
Source PublicationChinese Journal of Integrative Medicine
ISSN1672-0415
Volume22Issue:6Pages:420
Abstract

Objective: This study aimed at investigating whether notoginsenoside R1 (R1), a unique saponin found in Panax notoginseng could promote angiogenic activity on human umbilical vein endothelial cells (HUVECs) and elucidate their potential molecular mechanisms. In addition, vascular restorative activities of R1 was assessed in a chemically-induced blood vessel loss model in zebrafish. Methods: The in vitro angiogenic effect of R1 was compared with other previously reported angiogenic saponins Rg1 and Re. The HUVECs proliferation in the presence of R1 was determined by cell proliferation kit II (XTT) assay. R1, Rg1 and Re-induced HUVECs invasion across polycarbonate membrane was stained with Hoechst-33342 and quantified microscopically. Tube formation assay using matrigelcoated wells was performed to evaluate the pro-angiogenic actions of R1. In order to understand the mechanism underlying the pro-angiogenic effect, various pathway inhibitors such as SU5416, wortmannin (wort) or L-Nω-nitro- L-arginine methyl ester hydrochloride (L-NAME), SH-6 were used to probe the possible involvement of signaling pathway in the R1 mediated HUVECs proliferation. In in vivo assays, zebrafish embryos at 21 hpf were pre-treated with vascular endothelial growth factor (VEGF) receptor kinase inhibitor II (VRI) for 3 h only and subsequently post-treated with R1 for 48 h, respectively. The intersegmental vessels (ISVs) in zebrafish were assessed for the restorative effect of R1 on defective blood vessels. Results: R1 could stimulate the proliferation of HUVECs. In the chemoinvasion assay, R1 significantly increased the number of cross-membrane HUVECs. In addition, R1 markedly enhanced the tube formation ability of HUVECs. The proliferative effects of these saponins on HUVECs were effectively blocked by the addition of SU5416 (a VEGF-KDR/Flk-1 inhibitor). Similarly, pre-treatment with wort [a phosphatidylinositol 3-kinase (PI3K)-kinase inhibitor], L-NAME [an endothelial nitric oxide synthase (eNOS) inhibitor] or SH-6 (an Akt pathway inhibitor) significantly abrogated the R1 induced proliferation of HUVECs. In chemicallyinduced blood vessel loss model in zebrafish, R1 significantly rescue the damaged ISVs. Conclusion: R1, similar to Rg1 and Re, had been showed pro-angiogenic action, possibly via the activation of the VEGF-KDR/Flk-1 and PI3K-Akt-eNOS signaling pathways. Our findings also shed light on intriguing pro-angiogenic effect of R1 under deficient angiogenesis condition in a pharmacologic-induced blood vessels loss model in zebrafish. The present study in vivo and in vitro provided scientific evidence to explain the ethnomedical use of Panax notoginseng in the treatment of cardiovascular diseases, traumatic injuries and wound healing.

KeywordAngiogenesis Ginsenoside Re Ginsenoside Rg1 Human Umbilical Vein Endothelial Cell Notoginsenoside R1 Zebrafish
DOI10.1007/s11655-014-1954-8
URLView the original
Indexed BySCIE
Language英語English
WOS Research AreaIntegrative & Complementary Medicine
WOS SubjectIntegrative & Complementary Medicine
WOS IDWOS:000379011200003
The Source to ArticleScopus
Scopus ID2-s2.0-84919933552
Fulltext Access
Citation statistics
Document TypeJournal article
CollectionDEPARTMENT OF PHARMACEUTICAL SCIENCES
Institute of Chinese Medical Sciences
THE STATE KEY LABORATORY OF QUALITY RESEARCH IN CHINESE MEDICINE (UNIVERSITY OF MACAU)
Corresponding AuthorSimon Ming-Yuen Lee; CONG Wei-hong
Affiliation1.State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao, China
2.School of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China
3.Laboratory of Cardiovascular Diseases, Xiyuan Hospital China Heart Institute of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, 100091, China
First Author AffilicationInstitute of Chinese Medical Sciences
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
YANG Bin-rui,HONG Si-jia,Simon Ming-Yuen Lee,et al. Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo[J]. Chinese Journal of Integrative Medicine, 2014, 22(6), 420.
APA YANG Bin-rui., HONG Si-jia., Simon Ming-Yuen Lee., CONG Wei-hong., WAN Jian-bo., ZHANG Zhe-rui., ZHANG Qing-wen., ZHANG Yi., WANG Yi-tao., & LIN Zhi-xiu (2014). Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo. Chinese Journal of Integrative Medicine, 22(6), 420.
MLA YANG Bin-rui,et al."Pro-angiogenic activity of notoginsenoside R1 in human umbilical vein endothelial cells in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo".Chinese Journal of Integrative Medicine 22.6(2014):420.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[YANG Bin-rui]'s Articles
[HONG Si-jia]'s Articles
[Simon Ming-Yuen Lee]'s Articles
Baidu academic
Similar articles in Baidu academic
[YANG Bin-rui]'s Articles
[HONG Si-jia]'s Articles
[Simon Ming-Yuen Lee]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[YANG Bin-rui]'s Articles
[HONG Si-jia]'s Articles
[Simon Ming-Yuen Lee]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.